AccuDial Pharmaceutical Inc., Palm Beach Gardens, FL, announced that the Brazilian Patent and Trademark Office issued patent No. 0108453-4, relating to a device for calculating therapeutically correct doses of liquid medications based on a patient’s weight rather than age.
To find the correct dose, a parent rotates the AccuDial label until their child’s weight appears in the viewing window. Below the weight is the appropriate therapeutic dose. A dosing spoon is calibrated to match the dosing directions.
In January, Health Canada approved two of AccuDial’s OTC pediatric medications. The company is also working to obtain U.S. Food and Drug Administration approval in the U.S. More details and a video demonstration are available at www.accuratedose.com.
